Pharma Group Seeks Pause on Illinois Anti-Price Gouging Law (1)

The US trade group representing the generic drug and biosimilar industry wants a federal judge to put a hold on an Illinois law aimed at curbing price hikes, citing the industry’s past wins in challenging state drug pricing laws.

The Association for Accessible Medicines is likely to succeed on its claim that an Illinois law (Public Act 103-0367) that took effect Jan. 1 violates the commerce clause of the US Constitution because it regulates “prices charged in transactions wholly outside of Illinois,” the group argued in its motion for a preliminary injunction filed Feb. 2 in the US ...